The Ultimate Mitochondrial Matrix — SS-31 + MOTS-c + NAD+ & Advanced Tier
A comprehensive mitochondrial restoration protocol with two tiers. Foundation Tier: SS-31 (inner membrane repair), MOTS-c (biogenesis activation), NMN (NAD+ substrate), PQQ (PGC-1α stimulation). Advanced Tier adds Urolithin A (mitophagy) and Taurine (membrane stability). Designed for chronic fatigue, exercise performance decline, and mitochondrial age-related dysfunction.
Daily Schedule
Timing and dosage for each step
08:00 AM
20 mg
SS-31 subcutaneous injection. This is the foundation — repair existing mitochondrial membranes before stimulating biogenesis. 20mg/day or 0.25mg/kg body weight.
10:00 AM
10 mg
MOTS-c subcutaneous injection, 2 hours after SS-31. SS-31 first restores membrane structure; MOTS-c then activates AMPK to drive mitochondrial biogenesis. The sequence matters.
08:00 AM
500 mg
NMN 500mg orally with SS-31. Provides NAD+ substrate for the restored and newly generated mitochondria. A repaired ETC with abundant NAD+ maximises ATP production.
08:00 AM
20 mg
PQQ 20mg with breakfast. Stimulates PGC-1α, synergising with MOTS-c for mitochondrial biogenesis. Also acts as an antioxidant protecting newly formed mitochondria.
Morning
1000 mg
Advanced Tier. Urolithin A 500–1000mg oral (Mitopure preferred). Activates PINK1/Parkin mitophagy pathway — clears dysfunctional mitochondria so the pool is replenished with functional units.
Morning
4000 mg
Advanced Tier. Taurine 2–4g oral powder. Stabilises mitochondrial membrane potential, reduces ROS production, and maintains mitochondrial protein synthesis fidelity.
Protocol Overview
Mitochondrial dysfunction is a primary driver of fatigue, cognitive decline, and accelerated ageing. This protocol addresses it comprehensively across six complementary mechanisms, organised into two tiers.
Foundation Tier
The core four-compound stack targeting mitochondrial repair and biogenesis.
Layer 1 — SS-31: Repairs the inner mitochondrial membrane by binding cardiolipin, restoring cristae structure, and recovering electron transport chain efficiency. You cannot build on a broken foundation.
Layer 2 — MOTS-c: Activates AMPK signalling to drive mitochondrial biogenesis — the creation of new, healthy mitochondria. More mitochondria, with repaired structure.
Layer 3 — NMN: Provides NAD+ substrate. A restored electron transport chain with abundant NAD+ substrate produces maximum ATP output.
Layer 4 — PQQ: Activates PGC-1α independently of MOTS-c, providing additive biogenesis stimulation and antioxidant protection of newly formed mitochondria.
Why Sequencing Matters
The critical principle: repair before building. MOTS-c drives biogenesis — creating more mitochondria. But if the existing mitochondrial population is structurally compromised, new mitochondria inherit defective membrane characteristics. SS-31 must precede MOTS-c to establish a healthy mitochondrial template.
Hence the 2-hour gap: SS-31 at 8am, MOTS-c at 10am.
Advanced Tier
Once the Foundation Tier is established (4+ weeks), add these two compounds to address mitophagy and membrane stability.
Urolithin A — the only supplement with Phase 2 RCT data demonstrating enhanced mitophagy in humans (Andreux et al., Nature Metabolism, 2019). Urolithin A activates the PINK1/Parkin pathway, clearing dysfunctional mitochondria and allowing the pool to be replenished with functional units. 500–1000mg/day oral, Mitopure preferred.
Taurine — stabilises mitochondrial membrane potential, reduces mitochondrial ROS production, and maintains mitochondrial protein synthesis fidelity. Singh et al. (Science, 2023) identified taurine as a key longevity molecule with mitochondrial mechanisms. 2–4g/day oral powder.
Dosing Summary
| Compound | Dose | Timing | Route | Tier |
|---|---|---|---|---|
| SS-31 | 20mg/day | 08:00 AM | Subcutaneous injection | Foundation |
| MOTS-c | 10mg/week | 10:00 AM (2h after SS-31) | Subcutaneous injection | Foundation |
| NMN | 500mg/day | 08:00 AM | Oral | Foundation |
| PQQ | 20mg/day | 08:00 AM with breakfast | Oral | Foundation |
| Urolithin A | 500–1000mg/day | Morning | Oral (Mitopure preferred) | Advanced |
| Taurine | 2–4g/day | Morning | Oral powder | Advanced |
MOTS-c cycling: 8 weeks on, 4 weeks off.
Who This Protocol Is For
- Chronic fatigue syndrome / ME-CFS
- Post-viral fatigue (Long COVID mitochondrial dysfunction)
- Age-related exercise performance decline
- Mitochondrial myopathy (under physician supervision)
- Biohackers targeting cellular energy optimisation
Protocol Duration
Phase 1 (Weeks 1–4): Foundation Tier only — assess tolerance and subjective energy response Phase 2 (Weeks 5–8): Add Advanced Tier (Urolithin A + Taurine) if Foundation is well-tolerated Assessment: VO2max testing, subjective energy/fatigue scoring, CoQ10/lactate levels if available
Monitoring
Grip strength and VO2max (functional mitochondrial output), CoQ10 serum (mitochondrial health marker), lactate at rest (mitochondrial efficiency), and subjective energy levels on a consistent scale.
Supporting Interventions
- CoQ10 (ubiquinol) 200mg/day: electron transport chain cofactor
- Magnesium malate 400mg: ATP synthesis cofactor
- Cold exposure: activates PGC-1α independently
- Zone 2 training: primary stimulus for mitochondrial biogenesis
- Avoid alcohol: acute mitochondrial toxin
Disclaimer
SS-31 and MOTS-c are research peptides. NMN, PQQ, Urolithin A, and Taurine are supplements. This protocol is for educational purposes only.